Clinical trial
Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck…
NCT00256295 · Sai-Hong Ignatius Ou, Other · Terminated
Key facts
| NCT number | NCT00256295 |
|---|---|
| Title | Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer |
| Official title | A Phase II Study of Weekly Oxaliplatin and Gemcitabine Combination Chemotherapy for Recurrent or Metastatic Head and Neck Cancer |
| Lead sponsor | Sai-Hong Ignatius Ou, Other |
| Collaborators | Sanofi Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer of the Head and Neck |
| Intervention type | Drug |
| Interventions | Gemcitabine, Oxaliplatin |
| Enrollment | 8 |
| Start date | Apr 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Oct 1, 2011 |
| First posted | Nov 21, 2005 |
| Last update posted | Feb 1, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: